Posaconazole formulations not interchangeable

Tablet and oral suspension formulations of the antifungal posaconazole (Noxafil) are not interchangeable, warns the MHRA in its latest Drug Safety Update

Further information
View Noxafil drug record
Summary of Product Characteristics
MHRA Drug Safety Update

Prescribers should specify the dosage form on each prescription to avoid confusion.

Switching from oral solution to tablets, or vice versa, can result in over- or under-dosing and the risk of dose-related toxicity or lack of efficacy.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more